Virologic screening. Detection of high risk human papillomaviruses (HPV) has a high potential value for secondary prevention of cervical cancer. HPV testing can augment the sensitivity of conventional cytologic screening and can be used for triaging patients with a history of mild cytological abnormalities or low grade cervical intraepithelial neoplasia (CIN). Before screening for high risk HPVs can be generally recommended, refined commercially available HPV tests have to be established and their value has to shown in large epidemiologic studies.